Results 11 to 20 of about 47,585 (287)

Mineral bone disorder and osteoporosis in hemodialysis patients [PDF]

Advances in Rheumatology, 2020
Background Bone disease is common in patients undergoing hemodialysis. It is the result of bone turnover abnormalities and the decrease of bone mineral density (BMD). We aimed to determine the usefulness of serum bone turnover markers and BMD measurement
Maroua Slouma, Hela Sahli, Afef Bahlous, Lilia Laadhar, Wided Smaoui, Sonia Rekik, Imen Gharsallah, Meriem Sallami, Fatma Ben Moussa, Mohamed Elleuch, Elhem Cheour   +10 more
doaj   +3 more sources

Older Patients on Hemodiafiltration: Behavior of Uremic Toxins, Inflammation, Endothelium, and Bone Mineral Disorder

International Journal of Translational Medicine, 2022
Chronic kidney disease (CKD) affects 10% of the world’s population. Uremic toxins, such as indoxyl sulfate (IS), p-Cresylsulfate (PCS) and indole acetic acid (IAA), are not sufficiently removed by conventional hemodialysis (HD) and have been associated ...
Armando Morales-Jr, Walter Pereira Pinto, Vanessa Correa Fanchini, Luana Cristina de Almeida Silva, Thiago José Martins Gonçalves, Pamela Nithzi Bricher Choque, Fernanda Kussi, Lia Sumie Nakao, Rosilene Motta Elias, Maria Aparecida Dalboni   +9 more
doaj   +2 more sources

Mineral and bone disorders in peritoneal dialysis

Bulletin de la Dialyse à Domicile, 2022
Introduction Disorders of mineral and bone metabolism are common in dialysis patients and are responsible for an increased risk of fracture, cardiovascular risk and mortality. The mineral and bone disorder most frequently found in peritoneal dialysis
imane Houem, Mina Agrou, Imane Saidi, Naima Ouzeddoun, Rabia Bayahia, Loubna Benamar   +5 more
doaj   +2 more sources

Mineral and Bone Disorders After Kidney Transplantation [PDF]

Frontiers in Medicine, 2018
The risk of mineral and bone disorders among patients with chronic kidney disease is substantially elevated, owing largely to alterations in calcium, phosphorus, vitamin D, parathyroid hormone, and fibroblast growth factor 23. The interwoven relationship
Chandan Vangala, Jenny Pan, Ronald T. Cotton, Venkat Ramanathan   +3 more
doaj   +3 more sources

Sclerostin - a potential new marker of exercise influence on vascular calcification and mineral and bone disorder in hemodialysed adults [PDF]

Journal of Education, Health and Sport, 2019
Chronic Kidney Disease (CKD) is defined as abnormalities of kidney structure or function, present for >3 months, with implications for health. Amongst CKD complications the most fatal is cardiovascular disease, which together with Chronic Kidney ...
Agnieszka Turon-Skrzypinska, Grazyna Dutkiewicz, Malgorzata Marchelek-Myśliwiec, Aleksandra Ryl, Artur Uzdzicki, Tomasz Przybylski, Iwona Rotter   +6 more
doaj   +2 more sources

Bone Alkaline Phosphatase in CKD-Mineral Bone Disorder

American Journal of Kidney Diseases, 2013
Overall and cardiovascular mortality in patients with chronic kidney disease (CKD) is greatly increased, without obvious current effective treatments. Mineral and bone disorder (MBD) is a common manifestation of CKD and contributes to the high risk of ...
Goldsmith, David J A.,, Magnusson, Per, Sardiwal, Sunita, Magnusson, Per,, Goldsmith, David J. A., Sardiwal, Sunita,, Lamb, Edmund J.,, Lamb, Edmund J.   +7 more
core   +4 more sources

Electromagnetic field versus circuit weight training on bone mineral density in elderly women

Clinical Interventions in Aging, 2015
Hany Farid Eid Morsy Elsisi,1 Gihan Samir Mohamed Mousa,1 Mohamed Taher Mahmoud ELdesoky2 1Department of Physical Therapy for Cardiovascular/Respiratory Disorder and Geriatrics, 2Department of Basic Science, Faculty of Physical Therapy, Cairo University,
Elsisi HF, Mousa GS, ELdesoky MT
doaj   +1 more source

The Evolving World of Chronic Kidney Disease Mineral Bone Disorder [PDF]

European Medical Journal Nephrology, 2013
Chronic kidney disease – mineral and bone disorder (CKD-MBD) is associated with a significant morbidity and mortality. In vitro and animal models suggest that phosphorous, calcium, parathyroid hormone, and vitamin D abnormalities, mediate the ...
Antonio Bellasi, Andrea Galassi, Mario Cozzolino, Biagio Di Lorio   +3 more
doaj   +5 more sources

Hypophosphatasia: A Unique Disorder of Bone Mineralization [PDF]

International Journal of Molecular Sciences, 2021
Hypophosphatasia (HPP) is a rare genetic disease characterized by a decrease in the activity of tissue non-specific alkaline phosphatase (TNSALP). TNSALP is encoded by the ALPL gene, which is abundantly expressed in the skeleton, liver, kidney, and developing teeth. HPP exhibits high clinical variability largely due to the high allelic heterogeneity of
Juan Miguel Villa-Suárez, Cristina García-Fontana, Francisco Andújar-Vera, Sheila González-Salvatierra, Tomás de Haro-Muñoz, Victoria Contreras-Bolívar, Beatriz García-Fontana, Manuel Muñoz-Torres   +7 more
openaire   +4 more sources

Genetic Polymorphisms of RANK, RANKL and their relation to osteoporosis (Polimorfismos genéticos de RANK y RANKL y su relación con la osteoporosis) [PDF]

, 2012
[eng] Osteoporosis is a systemic skeletal disorder and the most common metabolic bone disease. It is recognized as one of the most prevalent problems facing postmenopausal women in western society. The World Health Organization definition of osteoporosis
Yoskovitz, Guy
core   +6 more sources